ACRO Testifies to FDA on Clinical Trial Modernization
Contact: John Lewis 202.464.9340 jlewis@www.acrohealth.org ACRO Testifies Before FDA on Clinical Trial Modernization Calls for Chief Innovation Officer April 23, 2012 –…
Contact: John Lewis 202.464.9340 jlewis@www.acrohealth.org ACRO Testifies Before FDA on Clinical Trial Modernization Calls for Chief Innovation Officer April 23, 2012 –…
Contact: John Lewis 202.464.9340 jlewis@www.acrohealth.org ACRO Launches YouTube Channel To Educate About Clinical Trials and CROs March 19, 2012 – WASHINGTON, DC –…
Contact: John Lewis 202.464.9340 jlewis@www.acrohealth.org Dateline NBC Report on Overseas Medical Research Strengthens ACRO Argument for Increased FDA Funding March 2, 2012 –…
Contact: John Lewis 202.464.9340 jlewis@www.acrohealth.org ACRO Implores CMS To Limit Research Definition For Sunshine Reporting February 17, 2012 – WASHINGTON, D.C….
February 17, 2012 Patient-Centered Outcomes Research Institute Public Comments 1701 Pennsylvania Ave. NW Suite 300 Washington, DC 20006 Re: Draft National Priorities for…
The Association of Clinical Research Organizations, whose members conduct an estimated two-thirds of the clinical trials in India, strongly disagrees with the…
Contact: John Lewis 202.464.9340 jlewis@www.acrohealth.org PharmaNet/i3 CEO Jeff McMullen Elected 2012 ACRO Chairman December 1, 2011 – WASHINGTON, D.C. – The Association of…
Contact: John Lewis 202.464.9340 jlewis@www.acrohealth.org ACRO Endorses Foreign Earnings Reinvestment Act October 6, 2011 – WASHINGTON, D.C. – The Association of Clinical Research…
Contact: John Lewis (O) 202.464.9340 (M) 202.285.5726 jlewis@www.acrohealth.org New ACRO Member Survey Shows Growth of CRO Industry Captures Range and Scope of…
Contact: John Lewis (O) 202.464.9340 (M) 202.285.5726 jlewis@www.acrohealth.org ACRO Recognizes World Heart Day With Focus on Clinical Research September 29, 2011 –…
Contact: John Lewis (O) 202.464.9340 (M) 202.285.5726 jlewis@www.acrohealth.org ACRO Executive Director Doug Peddicord Moderating Panel On HIPAA and Comparative Effectiveness Research at…
Contact: John Lewis (O) 202.464.2310 (M) 202.285.5726 john.lewis@www.acrohealth.org ACRO Files Brief with U.S. Supreme Court to Support Availability Of Prescription Data for…
Media Contact: John Lewis 202.464.2310 john.lewis@www.acrohealth.org ACRO EXECUTIVE DIRECTOR DISCUSSES DATA PRIVACY AND CER IN HEALTH AFFAIRS ARTICLE Washington, DC, November 2,…
Media Contact: John Lewis 202.464.2310 john.lewis@www.acrohealth.org ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS CALLS FOR ADDITIONAL FUNDING FOR FDA’S OVERSEAS OFFICES Washington,…
FOR IMMEDIATE RELEASE Media Contact: John Lewis 202.464.2310 (office) 202.285.5726 (mobile) john.lewis@www.acrohealth.org ACRO Pleased that Proposed HHS Privacy Rule Addresses Concerns…
Contact: John Lewis 202.464.2310 (office) 202.285.5726 (mobile) john.lewis@www.acrohealth.org ACRO Announces Agreement with University of Florida College of Pharmacy for Reduced Tuition Benefit Employees…
Media Contact: John Lewis 202.464.2310 (office) 202.285.5726 (mobile) john.lewis@www.acrohealth.org ACRO Responds to HHS Report on FDA Inspection of Foreign Clinical Trials…
Media Contact: Christina Plourde 202/587-2596 cplourde@spectrumscience.com ACRO Announces Findings from Groundbreaking Survey Exploring Barriers To Physician Participation in Clinical Research Results…
*ACRO Leadership Available for Interviews During Conference* Who: Executive Director, Doug Peddicord, Ph.D., and Vice President of Public Affairs, John Lewis, from the Association…
Contact: John Lewis 202.464.2310 (office) 202.285.5726 (mobile) john.lewis@www.acrohealth.org ACRO Applauds Appointment of Dr. Harold Varmus to Lead NCI Reform of Clinical Trials Process Should…